Literature DB >> 9681532

Associations of demographic and health-related characteristics with prostate cancer screening in Washington State.

D R Close1, A R Kristal, S Li, R E Patterson, E White.   

Abstract

This report describes associations of demographic and health-related characteristics with use of prostate cancer screening. Data are from a random-digit dial survey of Washington State residents. Analyses are restricted to men ages 40-79 years (n = 332) and examine both digital rectal examination (DRE) and blood tests for prostate-specific antigen (PSA) in the previous 2 years. Results are adjusted to be representative of the state's population. In 1996, 53.6% of men received either DRE, PSA, or both. Among those screened, 42% received DRE alone, 15% PSA alone, and 43% both PSA and DRE, and the percentages of men receiving PSA increased markedly with age (30%, ages 40-49 years; 58%, ages 50-59 years; and 77%, ages 60-79 years). After control for other demographic characteristics, the relative odds for any prostate cancer screening were 5.5 for ages 60-79 versus 40-49 years, 2.4 for 16+ versus < or = 12 years of education, and 4.0 for 2+ versus no physician visits in the previous 2 years (all P < 0.05). Characteristics generally associated with good health, including regular exercise and low fat and high fruit and vegetable intakes, were also significantly associated with prostate cancer screening. In conclusion, in 1996, approximately one-half of the men in Washington State over age 40 years had received prostate cancer screening in the previous 2 years. Few men were screened with PSA alone, and the use of PSA as part of prostate cancer screening increased markedly with age. Because PSA screening increases detection of prostate cancer, epidemiological studies of health behavior and cancer risk must carefully control for screening history to avoid detection bias.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9681532

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  13 in total

1.  [Is the prostate cancer screening behaviour of men with familial predisposition predictable?].

Authors:  T Paiss; D Kahn; R Küfer; C Maier; W Vogel; J E Gschwend; R E Hautmann; K Herkommer
Journal:  Urologe A       Date:  2005-04       Impact factor: 0.639

2.  A multilevel analysis of socioeconomic status and prostate cancer risk.

Authors:  Maureen Sanderson; Ann L Coker; Adriana Perez; Xianglin L Du; Gerson Peltz; Mary K Fadden
Journal:  Ann Epidemiol       Date:  2006-07-12       Impact factor: 3.797

3.  Psychological benefits of prostate cancer screening: the role of reassurance.

Authors:  Scott B Cantor; Robert J Volk; Alvah R Cass; Jawaria Gilani; Stephen J Spann
Journal:  Health Expect       Date:  2002-06       Impact factor: 3.377

4.  Colorectal cancer screening participation: comparisons with mammography and prostate-specific antigen screening.

Authors:  S Lemon; J Zapka; E Puleo; R Luckmann; L Chasan-Taber
Journal:  Am J Public Health       Date:  2001-08       Impact factor: 9.308

5.  Serum lycopene concentration and prostate cancer risk: results from the Prostate Cancer Prevention Trial.

Authors:  Alan R Kristal; Cathee Till; Elizabeth A Platz; Xiaoling Song; Irena B King; Marian L Neuhouser; Christine B Ambrosone; Ian M Thompson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-02-18       Impact factor: 4.254

6.  A 22-y prospective study of fish intake in relation to prostate cancer incidence and mortality.

Authors:  Jorge E Chavarro; Meir J Stampfer; Megan N Hall; Howard D Sesso; Jing Ma
Journal:  Am J Clin Nutr       Date:  2008-11       Impact factor: 7.045

7.  Smoking as a risk factor for prostate cancer: a meta-analysis of 24 prospective cohort studies.

Authors:  Michael Huncharek; K Sue Haddock; Rodney Reid; Bruce Kupelnick
Journal:  Am J Public Health       Date:  2009-07-16       Impact factor: 9.308

8.  Patient-Provider Communication About Prostate Cancer Screening and Treatment: New Evidence From the Health Information National Trends Survey.

Authors:  Soumitra S Bhuyan; Aastha Chandak; Niodita Gupta; Sudhir Isharwal; Chad LaGrange; Asos Mahmood; Dan Gentry
Journal:  Am J Mens Health       Date:  2016-07-07

9.  Serum Retinol and Carotenoid Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial.

Authors:  Sarah H Nash; Cathee Till; Xiaoling Song; M Scott Lucia; Howard L Parnes; Ian M Thompson; Scott M Lippman; Elizabeth A Platz; Jeannette Schenk
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-08-12       Impact factor: 4.254

10.  Factors related to use of prostate cancer screening: the Alberta Tomorrow Project.

Authors:  Harriet Richardson; Kristan J Aronson; Alison James; Elizabeth S McGregor; Heather Bryant
Journal:  Open Med       Date:  2007-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.